Emcure Pharmaceuticals Ltd (EMCURE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039308, "name": "Emcure Pharma", "stock_name": "Emcure Pharma", "full_name": "Emcure Pharmaceuticals Ltd", "name_url": "stocks-analysis/emcure-pharma", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "1,515.95", "chg": 32.5, "chgp": "2.19%", "dir": 1, "prev_price": "1,483.45", "mcapval": "27,981.00 Cr", "mcap": "Small Cap", "scripcode": 544210, "symbol": "EMCURE", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE168P01015", "curr_date": "Feb 06", "curr_time": "", "bse_nse_vol": "99.4 k", "exc_status": "Active", "traded_date": "Feb 06, 2026", "traded_date_str": "2026 02 06", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/emcure-pharma-10039308-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Emcure Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-ltd-is-rated-hold-3827178", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/EmcurePharmaceu_mojoScore_3827178.png", "date": "2026-02-08 10:10:29", "description": "Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 08 February 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Are Emcure Pharmaceuticals Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-emcure-pharmaceuticals-ltd-latest-results-good-or-bad-3822975", "imagepath": "", "date": "2026-02-05 19:34:47", "description": "Emcure Pharmaceuticals Ltd's latest financial results for Q3 FY26 reflect a continuation of its growth trajectory, with net sales reaching an all-time quarterly high of ₹2,363.48 crores, marking a year-on-year expansion of 20.42%. This growth demonstrates robust demand across key therapeutic segments and geographical markets. On a sequential basis, revenue advanced by 4.13% from the previous quarter, indicating sustained commercial momentum.\n\nHowever, the profitability metrics present a more complex picture. The consolidated net profit for the quarter was ₹230.54 crores, representing a significant year-on-year increase of 49.97%. Despite this, there was a sequential decline of 5.31% from the previous quarter's profit of ₹243.46 crores, which raises questions about the sustainability of profit margins. The operating profit margin slightly contracted to 20.85% from 20.95% in the prior quarter, although it rem..." }, { "title": "Emcure Pharmaceuticals Q3 FY26: Strong Revenue Growth Meets Premium Valuation Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/emcure-pharmaceuticals-q3-fy26-strong-revenue-growth-meets-premium-valuation-concerns-3821098", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/EmcurePharmaceu_quaterlyResult_3821098.png", "date": "2026-02-04 18:03:54", "description": "Emcure Pharmaceuticals Ltd. delivered a robust performance in Q3 FY26, with consolidated net profit surging 49.97% year-on-year to ₹230.54 crores, driven by strong revenue momentum across domestic and export markets. The Pune-based pharmaceutical manufacturer, commanding a market capitalisation of ₹28,739 crores, posted net sales of ₹2,363.48 crores during the quarter, marking a 20.42% YoY expansion. However, the stock's premium valuation at 36x trailing earnings and a sequential decline in profitability have prompted caution amongst investors, with shares trading at ₹1,533.70, reflecting a modest 1.86% gain in the latest session." }, { "title": "Emcure Pharmaceuticals Downgraded to Hold Amid Valuation Concerns Despite Strong Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-downgraded-to-hold-amid-valuation-concerns-despite-strong-financials-3806901", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/EmcurePharmaceu_mojoScore_3806901.png", "date": "2026-01-28 08:33:53", "description": "Emcure Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold as of 27 January 2026, reflecting a nuanced reassessment of its valuation and growth prospects despite robust financial performance and strong management efficiency. The revised rating follows a detailed analysis across four key parameters: Quality, Valuation, Financial Trend, and Technicals." }, { "title": "Emcure Pharmaceuticals Ltd Falls 2.44%: 3 Key Factors Driving the Weekly Move", "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-falls-244-3-key-factors-driving-the-weekly-move-3802827", "imagepath": "", "date": "2026-01-24 09:02:24", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>19 Jan:</strong> New 52-week high at Rs.1,585.50</p>\n <p><strong>20 Jan:</strong> Upgrade to Buy rating by MarketsMOJO</p>\n <p><strong>20 Jan:</strong> Technical momentum shifts to bullish outlook</p>\n <p><strong>23 Jan:</strong> Week closes at Rs.1,520.95 (-2.44%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,559.05</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,520.95</div><div class=\"stat-change negative\">-2.44%</di..." }, { "title": "When is the next results date for Emcure Pharmaceuticals Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-emcure-pharmaceuticals-ltd-3802608", "imagepath": "", "date": "2026-01-23 23:16:40", "description": "The next results date for Emcure Pharmaceuticals Ltd is scheduled for February 4, 2026...." }, { "title": "Emcure Pharmaceuticals Upgraded to Buy on Strong Technical and Financial Performance", "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-upgraded-to-buy-on-strong-technical-and-financial-performance-3795553", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/EmcurePharmaceu_mojoScore_3795553.png", "date": "2026-01-20 08:37:22", "description": "Emcure Pharmaceuticals Ltd has seen its investment rating upgraded from Hold to Buy, reflecting a marked improvement in its technical indicators, financial health, valuation metrics, and overall quality. This upgrade, effective from 19 January 2026, comes amid robust quarterly results, positive market trends, and growing institutional interest, signalling renewed investor confidence in the small-cap pharmaceutical player." }, { "title": "Emcure Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-3795403", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/EmcurePharmaceu_technicaldot_3795403.png", "date": "2026-01-20 08:06:12", "description": "Emcure Pharmaceuticals Ltd has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish stance as of 19 Jan 2026. This change is underpinned by a confluence of positive technical indicators and robust price performance, positioning the stock favourably within the Pharmaceuticals & Biotechnology sector despite a modest intraday price dip." }, { "title": "Emcure Pharmaceuticals Ltd Hits New 52-Week High at Rs.1585.5", "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-hits-new-52-week-high-at-rs15855-3794418", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/EmcurePharmaceu_priceRelatedfactors_3794418.png", "date": "2026-01-19 10:24:26", "description": "Emcure Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.1585.5 today, marking a notable achievement in its stock performance amid a mixed market environment." } ], "total": 359, "sid": "10039308", "stock_news_url": "https://www.marketsmojo.com/news/emcure-pharmaceuticals-10039308" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "05-Feb-2026", "details": "Newspaper Publication of Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025.", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 04 2026.", "datetime": "04-Feb-2026", "details": "Outcome of Board Meeting held on February 04 2026.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Change in Management", "datetime": "04-Feb-2026", "details": "Re-appointment of Independent Directors of the Company.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Emcure Pharmaceuticals Ltd has declared <strong>30%</strong> dividend, ex-date: 14 Aug 25", "dt": "2025-08-14", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

19 Jan: New 52-week high at Rs.1,585.50

20 Jan: Upgrade to Buy rating by MarketsMOJO

20 Jan: Technical momentum shifts to bullish outlook

23 Jan: Week closes at Rs.1,520.95 (-2.44%)

-2.44%Read full news article

When is the next results date for Emcure Pharmaceuticals Ltd?

2026-01-23 23:16:40

The next results date for Emcure Pharmaceuticals Ltd is scheduled for February 4, 2026....

Read full news article

Emcure Pharmaceuticals Upgraded to Buy on Strong Technical and Financial Performance

2026-01-20 08:37:22

Emcure Pharmaceuticals Ltd has seen its investment rating upgraded from Hold to Buy, reflecting a marked improvement in its technical indicators, financial health, valuation metrics, and overall quality. This upgrade, effective from 19 January 2026, comes amid robust quarterly results, positive market trends, and growing institutional interest, signalling renewed investor confidence in the small-cap pharmaceutical player.

Read full news article

Emcure Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-01-20 08:06:12

Emcure Pharmaceuticals Ltd has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish stance as of 19 Jan 2026. This change is underpinned by a confluence of positive technical indicators and robust price performance, positioning the stock favourably within the Pharmaceuticals & Biotechnology sector despite a modest intraday price dip.

Read full news article

Emcure Pharmaceuticals Ltd Hits New 52-Week High at Rs.1585.5

2026-01-19 10:24:26

Emcure Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.1585.5 today, marking a notable achievement in its stock performance amid a mixed market environment.

Read full news article